(Q54695588)
Statements
Clinical and immunologic responses of HLA-A3+ breast cancer patients vaccinated with the HER2/neu-derived peptide vaccine, E75, in a phase I/II clinical trial. (English)
Ritesh Patil
Guy T Clifton
Jarrod P Holmes
Asna Amin
Mark G Carmichael
Jeremy D Gates
Linda H Benavides
Matthew T Hueman
Sathibalan Ponniah
George E Peoples
22 December 2009
210
2
140-147